Search
Glycogen Storage Disease Type Ia
go.drugbank.com/conditions/DBCOND0063604Drugs: Pariglasgene brecaparvovecSynonyms: Hepatorenal form of glycogen storage diseaseWillardiine
go.drugbank.com/drugs/DB04129ExperimentalWillardiine is a compound isolated from seeds of _Acacia willariana_.
Motuporin
go.drugbank.com/drugs/DB04738ExperimentalMotuporin is a toxin isolated from the marine sponge Thenonella swinhoie grey.
Bergapten
go.drugbank.com/drugs/DB12216InvestigationalBergapten is under investigation in clinical trial NCT00533195 (Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis).
Categories: Antipsoriatics for Systemic Use, Psoralens for Systemic UseFlorbetapir F-18
go.drugbank.com/drugs/DB09149ApprovedInvestigationalwho are being evaluated for Alzheimer's Disease (AD) and other causes of cognitive decline. … Marketed as the product Amyvid, florbetapir 18F is indicated for positron emission tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment
Fenspiride
go.drugbank.com/drugs/DB08979Investigational), as well as for maintenance treatment of asthma. … It is approved for use in Russia for the treatment of acute and chronic inflammatory diseases of ENT organs and the respiratory tract (like rhinopharyngitis, laryngitis, tracheobronchitis, otitis and sinusitis
Categories: Drugs for Obstructive Airway DiseasesCilostazol
go.drugbank.com/drugs/DB01166ApprovedInvestigationalIt is marketed under the brand name Pletal by Otsuka Pharmaceutical Co.. Cilostazol works by inhibiting both primary and secondary aggregation and reducing calcium-induced contractions.
Categories: Compounds used in a research, industrial, or household settingBiapenem
go.drugbank.com/drugs/DB13028InvestigationalIt is a carbapenem antibiotic with a methyl group on the 1-beta position, which gives it stability against degradation by dehydropeptidase I.[A275008]
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseNangibotide
go.drugbank.com/drugs/DB16247InvestigationalNangibotide is under investigation in clinical trial NCT04055909 (Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock).
NP2
go.drugbank.com/drugs/DB06308InvestigationalIt was under investigation in clinical trial NCT01291901 (NP2 Enkephalin For Treatment of Intractable Cancer Pain).